Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.57+1.05 (+23.12%)
Close on Nov 18, 2026Market cap $349.72MP/E –Yield –
Cytosorbents shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cytosorbents's shares outstanding was 63M at Jun 30, 2026. For fiscal 2025 it was 62M, up 14.3% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is 62M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 62M | +14.3% |
| FY2024 | Dec 31, 2024 | 54M | +21.9% |
| FY2023 | Dec 31, 2023 | 45M | +2.5% |
| FY2022 | Dec 31, 2022 | 44M | +0.5% |
| FY2021 | Dec 31, 2021 | 43M | +11.7% |
| FY2020 | Dec 31, 2020 | 39M | +20.3% |
| FY2019 | Dec 31, 2019 | 32M | +5.0% |
| FY2018 | Dec 31, 2018 | 31M | +11.2% |
| FY2017 | Dec 31, 2017 | 28M | +8.6% |
| FY2016 | Dec 31, 2016 | 25M | +2.2% |
| FY2015 | Dec 31, 2015 | 25M | +73.0% |
| FY2014 | Dec 31, 2014 | 14M | +52.3% |
| FY2013 | Dec 31, 2013 | 9M | +19.1% |
| FY2012 | Dec 31, 2012 | 8M | +23.7% |
| FY2011 | Dec 31, 2011 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 63M | -6.5% |
| Q1 FY2026 | Mar 31, 2026 | 63M | +3.3% |
| Q4 FY2025 | Dec 31, 2025 | 63M | +14.8% |
| Q3 FY2025 | Sep 30, 2025 | 63M | +15.2% |
| Q2 FY2025 | Jun 30, 2025 | 67M | +23.7% |
| Q1 FY2025 | Mar 31, 2025 | 61M | +11.6% |
| Q4 FY2024 | Dec 31, 2024 | 55M | +17.5% |
| Q3 FY2024 | Sep 30, 2024 | 54M | +22.7% |
| Q2 FY2024 | Jun 30, 2024 | 54M | +23.4% |
| Q1 FY2024 | Mar 31, 2024 | 54M | +24.6% |
| Q4 FY2023 | Dec 31, 2023 | 47M | +6.7% |
| Q3 FY2023 | Sep 30, 2023 | 44M | +1.8% |
| Q2 FY2023 | Jun 30, 2023 | 44M | +1.0% |
| Q1 FY2023 | Mar 31, 2023 | 44M | +0.4% |
| Q4 FY2022 | Dec 31, 2022 | 44M | +0.4% |
| Q3 FY2022 | Sep 30, 2022 | 44M | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 44M | +0.6% |
| Q1 FY2022 | Mar 31, 2022 | 43M | +0.4% |
| Q4 FY2021 | Dec 31, 2021 | 43M | +0.6% |
| Q3 FY2021 | Sep 30, 2021 | 43M | +4.3% |
| Q2 FY2021 | Jun 30, 2021 | 43M | +18.7% |
| Q1 FY2021 | Mar 31, 2021 | 43M | +27.5% |
| Q4 FY2020 | Dec 31, 2020 | 43M | +33.2% |
| Q3 FY2020 | Sep 30, 2020 | 42M | +28.5% |
| Q2 FY2020 | Jun 30, 2020 | 36M | +13.1% |
| Q1 FY2020 | Mar 31, 2020 | 34M | +6.4% |
| Q4 FY2019 | Dec 31, 2019 | 32M | +2.4% |
| Q3 FY2019 | Sep 30, 2019 | 32M | +3.4% |
| Q2 FY2019 | Jun 30, 2019 | 32M | +6.5% |
| Q1 FY2019 | Mar 31, 2019 | 32M | +8.8% |
| Q4 FY2018 | Dec 31, 2018 | 32M | +10.2% |
| Q3 FY2018 | Sep 30, 2018 | 31M | +11.0% |
| Q2 FY2018 | Jun 30, 2018 | 30M | +8.4% |
| Q1 FY2018 | Mar 31, 2018 | 29M | +15.1% |
| Q4 FY2017 | Dec 31, 2017 | 29M | +12.9% |
| Q3 FY2017 | Sep 30, 2017 | 28M | +10.9% |
| Q2 FY2017 | Jun 30, 2017 | 28M | – |
| Q1 FY2017 | Mar 31, 2017 | 26M | – |
| Q4 FY2016 | Dec 31, 2016 | 25M | – |
| Q3 FY2016 | Sep 30, 2016 | 25M | – |
See a number that looks wrong?